SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-012031
Filing Date
2018-11-06
Accepted
2018-11-06 06:26:41
Documents
69
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cbmg_10q.htm 10-Q 1350437
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF cbmg_ex311.htm EX-31.1 18171
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cbmg_ex321.htm EX-32.1 8436
4 IMAGE cbmg_img1.jpg GRAPHIC 38481
5 IMAGE cbmg_img2.jpg GRAPHIC 36404
  Complete submission text file 0001654954-18-012031.txt   3813888

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cmbg-20180930.xml EX-101.INS 491414
7 XBRL TAXONOMY EXTENSION SCHEMA cmbg-20180930.xsd EX-101.SCH 35100
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmbg-20180930_cal.xml EX-101.CAL 52261
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmbg-20180930_def.xml EX-101.DEF 92264
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmbg-20180930_lab.xml EX-101.LAB 239607
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmbg-20180930_pre.xml EX-101.PRE 186340
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36498 | Film No.: 181161425
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences